Relafen 750, chemically designated as naproxol, showcases a fascinating case study from a biochemical pharmacy viewpoint. Its mechanism of reducing inflammation involves the specific inhibition of cyclooxygenase-2 (COX-2), an enzyme crucial for the production of prostanoids, potent agents of inflammation and pain. Unlike older NSAIDs, Relafen 750's